Continuous subcutaneous insulin infusion (CSII) in the management of diabetic lipodystrophy: a case report

Acta Diabetol Lat. 1987 Apr-Jun;24(2):165-7. doi: 10.1007/BF02742855.

Abstract

A case of diabetic lipodystrophy which showed an improvement after continuous subcutaneous insulin infusion into lipodystrophic areas is reported. The authors feel that this therapeutic regimen could be useful when conventional treatments (the injection of regular purified insulin or dexamethasone-insulin mixtures in the area of the lesion) have failed to obtain good results.

Publication types

  • Case Reports

MeSH terms

  • Blood Glucose / metabolism
  • Diabetes Mellitus, Type 1 / blood
  • Diabetes Mellitus, Type 1 / complications*
  • Female
  • Humans
  • Injections, Subcutaneous
  • Insulin / administration & dosage
  • Insulin / therapeutic use*
  • Lipodystrophy / drug therapy*
  • Lipodystrophy / etiology
  • Middle Aged

Substances

  • Blood Glucose
  • Insulin